Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label long-term ganaxolone treatment in infantile spasms
2006-004286-33Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Mar 2007
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ganaxolone in West syndrome, sponsored by Marinus Pharmaceuticals. Primary endpoint: Spasm-free status at Week 32. Started Mar 2007; status: completed.
02
Drugs
ganaxolone
03
Conditions
West syndrome
Beyond the preview
Go deeper on 2006-004286-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004286-33.